Celgene is a preeminent global biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for patients with cancer, immune-inflammatory, and other unmet medical needs.

We are focused on drugs that can make a meaningful difference to patients, including rare and debilitating diseases like multiple myeloma, myelodysplastic syndromes, solid tumour cancers, lymphomas, and immune-inflammatory diseases.

Website: www.celgene.com